Tokyo .- A university in Japan announced today that it has done the first stem cell transplantation of induced pluripotency (iPS) to treat malignancy parkinsonian.
The transplant, the first of its kind in the world for treatment of Parkinson's, was conducted last month by the University Hospital in Kyoto, reported the training center today.
The recipient was a patient about 50 years whose identity was not provided, which will be subject to periodic checks for two years to avoid rejection.
"We made a tension on the left side of the head (by the patient) and transplanted 2.4 million cells," says Takayuki Kikuchi from Kyoto University to journalists, according to Kyodo News Agency.
The cells used were created using iPS stem cells from donors that have some type of immunity that makes them less likely to reject transplants.
the Parkinson's disease, which means chronic degeneration of the neurons, still has no cure. Only in Japan It is estimated that there are 160,000 people with progressive neurological disorders.
On March 29, 2017, researchers from Kobe General Medical Center, in western Japan, announced the first surgical transplant in humans with iPS cells in the retina of a patient.
The patient who suffered from macular degeneration of the retina – an uneven ocular obstruction that can cause blindness – received an injection of a retinal cell solution developed from other iPS from a donor.